aducanumab

You have access
Impact of Reference and Target Region Selection on Amyloid PET SUV Ratios in the Phase 1b PRIME Study of Aducanumab
Ping Chiao, Barry J. Bedell, Brian Avants, Alex P. Zijdenbos, Marilyn Grand'Maison, Paul O’Neill, John O’Gorman, Tianle Chen and Robert Koeppe

Journal of Nuclear Medicine January 1, 2019, 60 (1) 100-106; DOI: https://doi.org/10.2967/jnumed.118.209130